Klaria Pharma Holding Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Klaria Pharma Holding
Access all reports
Klaria Pharma Holding AB is a Swedish biotechnology and medical research company focused on developing and commercializing therapeutic drugs. The company's core technology involves a patented drug delivery platform using an alginate-based polymer film that facilitates rapid and reliable transmucosal absorption. This innovative method allows the medication to be distributed directly into the bloodstream via a mucoadhesive film, offering benefits such as shorter time to effect, increased control, and simple handling. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
Walmart: Walton, Retailing, and Everyday Low Prices
Walmart was founded in 1962 by Sam Walton, and has grown to become the largest retailer in the world, employing more than 2.1 million people worldwide.
17 Oct 2024
Texas Instruments: From Calculators to Master Capital Allocators
Texas Instruments has undergone many transformations from its origins in oil exploration to become one of the world's largest semiconductor producers.
11 Oct 2024
The Art of Portfolio Management: Lessons from Tom O'Hara
Tom O'Hara shares insights on stock picking, navigating market distractions, and the importance of one-on-one meetings with management teams.
4 Oct 2024
Ticker symbol
KLAR
Country
🇸🇪 Sweden